Viatris, Inc. recalls Telmisartan and Amlodipine
FDA Class III
FDA classified this recall as Class III: the product is unlikely to cause health problems but breaks the agency's rules (a labeling mistake, for example).
- What's wrong
- Superpotent Drug: potential for the Telmisartan content in these lots to exceed specifications
- Products
-
- Telmisartan and Amlodipine
- Company
- Viatris, Inc.
- Where it was sold
-
Nationwide in the USA.
- Units affected
- 21,620 30-count bottles
- Status
- Ongoing
Recall Relay is not affiliated with or endorsed by FDA or any agency. Details here are copied from the FDA notice and may lag behind it; the official notice is always the final word.